- Home
- IMRN vs TLPH Comparison
IMRN vs TLPH Comparison
Compare IMRN & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- TLPH
- Stock Information
- Founded
- IMRN 1994
- TLPH 2005
- Country
- IMRN Australia
- TLPH United States
- Employees
- IMRN N/A
- TLPH N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- IMRN Health Care
- TLPH Health Care
- Exchange
- IMRN Nasdaq
- TLPH Nasdaq
- Market Cap
- IMRN 15.0M
- TLPH 13.4M
- IPO Year
- IMRN N/A
- TLPH 2011
- Fundamental
- Price
- IMRN $1.81
- TLPH $0.69
- Analyst Decision
- IMRN Strong Buy
- TLPH Strong Buy
- Analyst Count
- IMRN 1
- TLPH 2
- Target Price
- IMRN $5.00
- TLPH $4.50
- AVG Volume (30 Days)
- IMRN 6.2K
- TLPH 76.0K
- Earning Date
- IMRN 11-26-2024
- TLPH 11-13-2024
- Dividend Yield
- IMRN N/A
- TLPH N/A
- EPS Growth
- IMRN N/A
- TLPH N/A
- EPS
- IMRN N/A
- TLPH N/A
- Revenue
- IMRN $3,271,194.00
- TLPH $281,000.00
- Revenue This Year
- IMRN N/A
- TLPH N/A
- Revenue Next Year
- IMRN N/A
- TLPH N/A
- P/E Ratio
- IMRN N/A
- TLPH N/A
- Revenue Growth
- IMRN 171.67
- TLPH N/A
- 52 Week Low
- IMRN $1.59
- TLPH $0.46
- 52 Week High
- IMRN $5.96
- TLPH $1.61
- Technical
- Relative Strength Index (RSI)
- IMRN 35.96
- TLPH 32.96
- Support Level
- IMRN $1.73
- TLPH $0.65
- Resistance Level
- IMRN $1.99
- TLPH $0.93
- Average True Range (ATR)
- IMRN 0.12
- TLPH 0.08
- MACD
- IMRN 0.02
- TLPH -0.03
- Stochastic Oscillator
- IMRN 20.42
- TLPH 11.46
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.